Published Application/Species/Sample/Dilution | Reference |
---|
- flow cytometry; human; 1:20; loading ...; fig 2d
| Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto Vila M, Hosaka K, et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. elife. 2019;8: pubmed publisher
|
| Izar B, Tirosh I, Stover E, Wakiro I, Cuoco M, Alter I, et al. A single-cell landscape of high-grade serous ovarian cancer. Nat Med. 2020;26:1271-1279 pubmed publisher
|
| Slyper M, Porter C, Ashenberg O, Waldman J, DROKHLYANSKY E, Wakiro I, et al. A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors. Nat Med. 2020;26:792-802 pubmed publisher
|
| Rosser E, Piper C, Matei D, Blair P, Rendeiro A, Orford M, et al. Microbiota-Derived Metabolites Suppress Arthritis by Amplifying Aryl-Hydrocarbon Receptor Activation in Regulatory B Cells. Cell Metab. 2020;31:837-851.e10 pubmed publisher
|
| Fritz A, Hong D, Boyd J, Kost J, Finstaad K, Fitzgerald M, et al. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells. J Cell Physiol. 2020;235:7261-7272 pubmed publisher
|
| Upasani V, Vo H, Ung S, Heng S, Laurent D, Choeung R, et al. Impaired Antibody-Independent Immune Response of B Cells in Patients With Acute Dengue Infection. Front Immunol. 2019;10:2500 pubmed publisher
|
| Hong D, Fritz A, Finstad K, Fitzgerald M, Weinheimer A, Viens A, et al. Suppression of Breast Cancer Stem Cells and Tumor Growth by the RUNX1 Transcription Factor. Mol Cancer Res. 2018;16:1952-1964 pubmed publisher
|
| Luo M, Shang L, Brooks M, Jiagge E, Zhu Y, Buschhaus J, et al. Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling. Cell Metab. 2018;28:69-86.e6 pubmed publisher
|
| Deshmukh A, Arfuso F, Newsholme P, Dharmarajan A. Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4). Cancers (Basel). 2018;10: pubmed publisher
|
| Aravena O, Ferrier A, Menon M, Mauri C, Aguillon J, Soto L, et al. TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients. Arthritis Res Ther. 2017;19:8 pubmed publisher
|
| Joosten S, van Meijgaarden K, Del Nonno F, Baiocchini A, Petrone L, Vanini V, et al. Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment. PLoS Pathog. 2016;12:e1005687 pubmed publisher
|
| Mohiuddin M, Singh A, Corcoran P, Thomas Iii M, Clark T, Lewis B, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft. Nat Commun. 2016;7:11138 pubmed publisher
|
| Ames E, Canter R, Grossenbacher S, Mac S, Chen M, Smith R, et al. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J Immunol. 2015;195:4010-9 pubmed publisher
|
| Bagnara D, Squillario M, Kipling D, Mora T, Walczak A, Da Silva L, et al. A Reassessment of IgM Memory Subsets in Humans. J Immunol. 2015;195:3716-24 pubmed publisher
|
| Hamilton K, Noubissi F, Katti P, Hahn C, Davey S, Lundsmith E, et al. IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts. Carcinogenesis. 2013;34:2647-54 pubmed publisher
|
| Ordonez M, Roberts E, Kidwell C, Yuan S, Plaisted W, Goldstein L. Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1. Hum Mol Genet. 2012;21:2651-62 pubmed publisher
|